Peroxisome Proliferator-Activated Receptors in Lung Cancer
2007
Peroxisome Proliferator-Activated Receptors in Lung Cancer
publication
Evidence: moderate
Author Information
Author(s): Keshamouni Venkateshwar G., Han ShouWei, Roman Jesse
Primary Institution: University of Michigan, Emory University, Atlanta Veterans Affairs Medical Center
Hypothesis
Are PPARs potential therapeutic targets for lung cancer treatment?
Conclusion
PPAR-γ activation is associated with decreased lung carcinoma cell proliferation and may serve as a therapeutic target.
Supporting Evidence
- PPAR-γ ligands induce growth arrest and promote apoptosis in lung carcinoma cell lines.
- Activation of PPAR-γ is correlated with tumor histological type and grade.
- PPAR-γ ligands can inhibit angiogenesis and tumor vascularization.
Takeaway
PPARs are proteins that can help control cancer growth, and scientists are studying how they might be used to treat lung cancer.
Methodology
This review summarizes existing research on PPARs and their role in lung cancer biology.
Limitations
The roles of PPAR-α and PPAR-β/δ in lung cancer remain uncertain and require further investigation.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website